(Q46058170)

19 December 2017

title

An investigation of the subacute effects of ecstasy on neuropsychological performance, sleep and mood in regular ecstasy users (English)

1 reference

19 December 2017

1 reference

A Pirona

1

1 reference

19 December 2017

M J Morgan

series ordinal

2

1 reference

19 December 2017

language of work or name

English

0 references

publication date

7 April 2009

1 reference

19 December 2017

Journal of Psychopharmacology

published in

1 reference

19 December 2017

volume

24

1 reference

19 December 2017

issue

2

1 reference

19 December 2017

page(s)

175-185

1 reference

19 December 2017

Insensitivity to future consequences following damage to human prefrontal cortex

cites work

1 reference

https://api.crossref.org/works/10.1177%2F0269881109102780

An Inventory for Measuring Depression

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881109102780

Ecstasy abuse and dependence among adolescents and young adults: applicability and reliability of DSM-IV criteria.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881109102780

Empathy and aggression: two faces of ecstasy? A study of interpretative cognitive bias and mood change in ecstasy users

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881109102780

MDMA (ecstasy) pharmacokinetics in a CYP2D6 poor metaboliser and in nine CYP2D6 extensive metabolisers.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881109102780

Neurocognitive consequences of sleep deprivation

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881109102780

The acute and sub-acute effects of 'ecstasy' (MDMA) on processing of facial expressions: preliminary findings

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881109102780

The sub-acute effects of recreational ecstasy (MDMA) use: a controlled study in humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881109102780

The serotonin uptake inhibitor citalopram reduces acute cardiovascular and vegetative effects of 3,4-methylenedioxymethamphetamine ('Ecstasy') in healthy volunteers.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881109102780

Acute psychological and physiological effects of MDMA ("Ecstasy") after haloperidol pretreatment in healthy humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881109102780

Acute psychological effects of 3,4-methylenedioxymethamphetamine (MDMA, "Ecstasy") are attenuated by the serotonin uptake inhibitor citalopram

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881109102780

Psychological and physiological effects of MDMA ("Ecstasy") after pretreatment with the 5-HT(2) antagonist ketanserin in healthy humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881109102780

Recreational use of "ecstasy" (MDMA) is associated with elevated impulsivity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881109102780

Memory deficits associated with recreational use of "ecstasy" (MDMA).

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881109102780

Ecstasy (MDMA): a review of its possible persistent psychological effects

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881109102780

Elevated impulsivity and impaired decision-making in abstinent Ecstasy (MDMA) users compared to polydrug and drug-naïve controls.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881109102780

Ecstasy (MDMA): are the psychological problems associated with its use reversed by prolonged abstinence?

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881109102780

Ecstasy (MDMA) effects upon mood and cognition: before, during and after a Saturday night dance.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881109102780

Is ecstasy MDMA? A review of the proportion of ecstasy tablets containing MDMA, their dosage levels, and the changing perceptions of purity

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881109102780

Chronic tolerance to recreational MDMA (3,4-methylenedioxymethamphetamine) or Ecstasy

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881109102780

Recreational MDMA use in Sydney: a profile of 'Ecstacy' users and their experiences with the drug

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881109102780

Self-reported depressive symptomatology in community samples of polysubstance misusers who report Ecstasy use: a meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881109102780

The varieties of ecstatic experience: an exploration of the subjective experiences of ecstasy

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881109102780

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881109102780

Sub-acute effects of MDMA (+/-3,4-methylenedioxymethamphetamine, "ecstasy") on mood: evidence of gender differences

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881109102780

Acute, sub‐acute and long‐term subjective consequences of ‘ecstasy’ (MDMA) consumption in 430 regular users

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881109102780

Psychological and Cardiovascular Effects and Short-Term Sequelae of MDMA (“Ecstasy”) in MDMA-Naïve Healthy Volunteers

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881109102780

Drugs and the dance music scene: a survey of current drug use patterns among a sample of dance music enthusiasts in the UK.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881109102780

21 January 2018

Identifiers

DOI

10.1177/0269881109102780

1 reference

19 December 2017

PubMed ID

19351799

1 reference

19 December 2017